Manufacturer record

Accuwell Medics Pvt Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Accuwell Medics Pvt Ltd (Gujarat) were declared Not of Standard Quality between May 2025 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: AT24/817, Ofloxacin & Ornidazole Tablets IP (exp Dec 2026). RDTL, Bellary, Karnataka (state lab) found it not of standard quality: Test for Uniformity of Weight of Tablets, Assay for Ofloxacin and Test for Dissolution of Ofloxacin and Ornidazole. Listed in the August 2026 alert.

Records by type

3 records linked to Accuwell Medics Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2025 to Aug 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2025
3
Products affected
Assay
Most common failure
Aug 2026
Latest alert

Flagged batches per year

2025 · 12026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ofloxacin & Ornidazole Tablets IP Batch AT24/817Mfg Jan 2025 · Exp Dec 2026 Test for Uniformity of Weight of Tablets, Assay for Ofloxacin and Test for Dissolution of Ofloxacin and OrnidazoleAssay RDTL, Bellary, KarnatakaState lab Aug 2026
Albendazole Tablets I.P. 400 mg Batch AT25/120Mfg May 2025 · Exp Apr 2027 The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Albendazole.Dissolution RDTL, GuwahatiCDSCO lab May 2026
Park 650 Batch AT24/391Mfg Aug 2024 · Exp Jul 2026 The sample fails in the test for Uniformity of Weight of Tablets & Assay content of ParacetamolAssay Modern Drug Testing Laboratory Kathua (J&K)State lab May 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.